[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-001", "question": "A 45-year-old man with a history of migraine presents with acute onset of right-sided hemiparesis and aphasia. MRI shows restricted diffusion in the left middle cerebral artery territory, but no large vessel occlusion on angiography. Lumbar puncture reveals normal opening pressure, 5 WBCs/μL (all lymphocytes), protein 45 mg/dL, glucose 60 mg/dL, and negative oligoclonal bands. Serum testing is positive for anti-NMDA receptor antibodies. What is the most appropriate next step in management?", "options": ["Initiate intravenous thrombolysis", "Administer high-dose intravenous methylprednisolone", "Start rituximab infusion", "Perform plasmapheresis", "Administer acyclovir empirically"], "answer": "C", "answer_index": 2, "explanation": "The presentation suggests anti-NMDA receptor encephalitis mimicking stroke, and rituximab is indicated for refractory cases or as first-line in severe presentations per subspecialty guidelines. High-dose steroids are often initial, but in antibody-positive cases with stroke-like features, rituximab targets B-cell depletion more effectively. Plasmapheresis is an alternative but not superior in this context without evidence of fulminant progression.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has acute stroke-like symptoms with MRI showing restricted diffusion in an MCA territory, but no large vessel occlusion.  \nLumbar puncture shows mild lymphocytic pleocytosis and slightly elevated protein, with normal glucose and no oligoclonal bands.  \nSerum anti-NMDA receptor antibodies are positive.  \n\nAnti-NMDA receptor encephalitis can present with focal neurological deficits, seizures, psychosis, and movement disorders.  \nAcute management for suspected autoimmune encephalitis with significant neurological deficits typically involves **immunotherapy**, starting with high-dose corticosteroids and/or IVIG or plasmapheresis.  \nGiven the acute presentation with stroke-like deficits and confirmed anti-NMDA receptor antibodies, first-line acute immunotherapy is **high-dose IV methylprednisolone** (often combined with IVIG or plasmapheresis, but steroids are a standard immediate intervention).  \n\nAmong the options:  \n- A (thrombolysis) is not indicated without evidence of ischemic stroke due to thrombosis and carries risk if inflammation is the cause.  \n- B (high-dose IV methylprednisolone) is appropriate initial immunotherapy.  \n- C (rituximab) is usually second-line, not first-line acute management.  \n- D (plasmapheresis) is also first-line but often after or with steroids; however, guidelines often recommend starting steroids first unless contraindicated.  \n- E (acyclovir) is for herpes encephalitis, which is less likely here given anti-NMDA antibodies positive and CSF not typical for viral encephalitis.  \n\nThe most appropriate **next step** among these is starting high-dose IV steroids.  \n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-002", "question": "A 62-year-old woman with Parkinson's disease on levodopa/carbidopa develops sudden visual hallucinations and paranoia. She has no fever, normal vital signs, and her Unified Parkinson's Disease Rating Scale score has worsened by 15 points. CSF analysis shows 10 WBCs/μL (mononuclear), protein 55 mg/dL, and negative PCR for herpes simplex virus. What is the most likely underlying mechanism?", "options": ["Dopaminergic overstimulation in mesolimbic pathways", "Alpha-synuclein aggregation in occipital lobes", "Autoimmune encephalitis with anti-LGI1 antibodies", "Lewy body deposition in limbic structures", "Serotonergic imbalance from medication withdrawal"], "answer": "C", "answer_index": 2, "explanation": "This scenario points to anti-LGI1 encephalitis, which can mimic psychiatric decompensation in Parkinson's patients and is associated with faciobrachial dystonic seizures or hallucinations. Dopaminergic effects are common but do not explain the CSF pleocytosis. Lewy body involvement is typical in dementia with Lewy bodies but lacks the acute inflammatory CSF findings here.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has Parkinson’s disease on levodopa, with acute/subacute neuropsychiatric changes (hallucinations, paranoia) and mild CSF pleocytosis with elevated protein, suggesting inflammation.  \nAutoimmune encephalitis (e.g., anti-LGI1) can cause rapid neuropsychiatric symptoms, CSF inflammation, and can occur in older adults, sometimes mimicking or complicating neurodegenerative diseases.  \nDopaminergic overstimulation (A) could explain hallucinations but not CSF inflammation or UPDRS worsening in this context.  \nAlpha-synuclein aggregation (B) and Lewy body deposition (D) are chronic processes, not acute.  \nSerotonergic imbalance from withdrawal (E) doesn’t fit, as she is still on levodopa.  \n\nThe answer is C"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-003", "question": "A 28-year-old woman at 32 weeks gestation presents with severe pelvic pain and vaginal bleeding. Ultrasound shows a low-lying placenta with abnormal lacunae and loss of the retroplacental clear space. MRI confirms myometrial thinning and turbulent flow voids. What is the most appropriate management strategy?", "options": ["Expectant management with bed rest", "Immediate cesarean delivery", "Uterine artery embolization", "Balloon tamponade post-delivery", "Prophylactic internal iliac artery ligation"], "answer": "E", "answer_index": 4, "explanation": "This describes placenta accreta spectrum, and prophylactic internal iliac artery ligation reduces hemorrhage risk during planned cesarean hysterectomy in high-risk cases. Immediate delivery risks uncontrolled bleeding without preparation. Embolization is adjunctive but not primary in antenatal planning for accreta.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The findings describe placenta percreta (low-lying placenta, lacunae, loss of retroplacental clear space, myometrial thinning, and turbulent flow voids on MRI) at 32 weeks with symptoms of severe pain and bleeding.  \n\nGiven the high risk of life-threatening hemorrhage, the definitive management is immediate delivery with cesarean hysterectomy (since placenta percreta will not separate and attempts at removal cause massive bleeding).  \n\nAmong the options:  \n- **A** (expectant management) is inappropriate with severe symptoms at 32 weeks.  \n- **B** (immediate cesarean delivery) is necessary, but in reality, this would be planned as a cesarean hysterectomy or with multidisciplinary preparedness for massive hemorrhage; among the given choices, it is the most appropriate step.  \n- **C, D, E** are adjuncts or procedures that may be used in management but are not the primary strategy for symptomatic placenta percreta at 32 weeks; definitive surgery is required.  \n\nThe best answer is **B**, understanding that in clinical context this implies proceeding to delivery with surgical control, usually hysterectomy.  \n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-004", "question": "A 35-year-old woman with endometriosis undergoes laparoscopic excision and develops postoperative fever, leukocytosis, and pelvic pain. CT shows a 5 cm complex adnexal mass with gas bubbles. Blood cultures are negative, but vaginal cultures grow mixed anaerobes. What is the most likely diagnosis?", "options": ["Ovarian abscess from bowel perforation", "Endometrioma superinfection", "Tubo-ovarian abscess from pelvic inflammatory disease", "Postoperative hematoma with secondary infection", "Clostridial myonecrosis of the uterus"], "answer": "A", "answer_index": 0, "explanation": "Bowel perforation during endometriosis surgery can lead to ovarian abscess with gas-forming anaerobes, explaining the imaging and cultures. Endometrioma infection is less likely without prior instrumentation. Tubo-ovarian abscess typically involves gonadal pathogens, not mixed anaerobes from bowel flora.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has a postoperative pelvic infection following laparoscopic excision for endometriosis. The CT findings of a complex adnexal mass with gas bubbles suggest an abscess containing gas-forming organisms. Vaginal cultures growing mixed anaerobes point to polymicrobial infection from genital tract flora.  \n\nGiven the recent surgery, the most likely source is bowel injury (a known complication of laparoscopic excision of endometriosis involving bowel adhesions), leading to an abscess from enteric organisms. This fits better than a tubo-ovarian abscess from pelvic inflammatory disease (which is usually not related to recent surgery) or superinfection of an endometrioma (less likely to produce gas bubbles unless bowel flora introduced).  \n\n"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-005", "question": "A 58-year-old man with hypertrophic cardiomyopathy presents with syncope. Echocardiogram shows left ventricular outflow tract gradient of 80 mmHg at rest, increasing to 120 mmHg with Valsalva. He is on beta-blockers but remains symptomatic. Genetic testing reveals a MYH7 mutation. What is the most appropriate next intervention?", "options": ["Alcohol septal ablation", "Surgical myectomy", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Mavacamten therapy"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten, a cardiac myosin inhibitor, is indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying MYH7-related hypercontractility. Alcohol ablation and myectomy are invasive options for severe cases, but mavacamten offers medical management first. ICD is for arrhythmia risk, not outflow obstruction.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has hypertrophic cardiomyopathy with a significant resting LVOT gradient that worsens with Valsalva, is refractory to beta-blockers, and is causing syncope.  \nIn symptomatic patients with drug-refractory obstructive HCM and severe septal hypertrophy, **surgical septal myectomy** is the gold standard invasive treatment, especially when there is a high gradient and syncope.  \nAlcohol septal ablation is an alternative but generally considered in patients with comorbidities or older age, while mavacamten is a newer medical option but not yet standard first-line invasive intervention. ICD placement is for sudden death risk reduction but does not treat outflow obstruction. Dual-chamber pacing is a less effective alternative when surgery/ablation are not suitable.  \n\nGiven the severity and failure of medical therapy, surgical myectomy is most appropriate.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-006", "question": "A 70-year-old woman with atrial fibrillation on apixaban develops acute chest pain. Coronary angiography shows spontaneous coronary artery dissection in the left anterior descending artery. She is hemodynamically stable with TIMI 3 flow. What is the most appropriate management?", "options": ["Percutaneous coronary intervention with stenting", "Continuation of apixaban with close monitoring", "Switch to dual antiplatelet therapy", "Surgical bypass grafting", "Conservative management with beta-blockers"], "answer": "E", "answer_index": 4, "explanation": "Conservative management with beta-blockers is preferred for stable spontaneous coronary artery dissection with preserved flow, as it promotes healing and reduces shear stress. Anticoagulation like apixaban increases bleeding risk in dissection. PCI is reserved for unstable cases due to high complication rates.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "Spontaneous coronary artery dissection (SCAD) in a hemodynamically stable patient with TIMI 3 flow is generally managed conservatively because instrumentation can extend the dissection.  \nBeta-blockers are recommended to reduce shear stress and myocardial oxygen demand.  \nAnticoagulation (apixaban) is typically discontinued due to risk of intramural hematoma extension, and antiplatelet therapy may be considered, but dual antiplatelet therapy is not the single best initial step if flow is already preserved.  \nThe most appropriate initial management in this stable scenario is conservative therapy with beta-blockers.  \n\nThe answer is E"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-007", "question": "A 40-year-old man returning from West Africa presents with fever, myalgias, and petechial rash. Labs show thrombocytopenia, elevated liver enzymes, and PCR positive for Lassa virus. He develops acute kidney injury with oliguria. What is the most appropriate therapeutic intervention?", "options": ["Intravenous ribavirin", "Supportive care with hemodialysis", "Convalescent plasma transfusion", "Favipiravir administration", "Monoclonal antibody therapy"], "answer": "A", "answer_index": 0, "explanation": "Intravenous ribavirin is the mainstay for Lassa fever, reducing mortality especially when initiated early, and it addresses viremia in cases with renal involvement. Supportive care is essential but not sufficient alone. Favipiravir is investigational and not standard for Lassa.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Lassa virus infection is an arenaviral hemorrhagic fever. Intravenous ribavirin is the recommended antiviral treatment, especially when given early in the course of illness, and it has been shown to reduce mortality. While supportive care including hemodialysis may be needed for complications like acute kidney injury, the question asks for the most appropriate therapeutic intervention, which is specific antiviral therapy.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-008", "question": "A 55-year-old immunocompromised patient with lung transplant develops dyspnea and ground-glass opacities on CT. Bronchoalveolar lavage PCR is positive for Pneumocystis jirovecii, but serum beta-D-glucan is negative. He is on trimethoprim-sulfamethoxazole prophylaxis. What explains the breakthrough infection?", "options": ["Dihydropteroate synthase gene mutation", "Non-adherence to prophylaxis", "Concurrent cytomegalovirus co-infection", "Inadequate dosing in obesity", "Atovaquone cross-resistance"], "answer": "A", "answer_index": 0, "explanation": "Mutations in the dihydropteroate synthase gene confer resistance to sulfamethoxazole in Pneumocystis, leading to breakthrough despite prophylaxis in immunocompromised hosts. Non-adherence is common but less likely with negative beta-D-glucan suggesting low burden. CMV co-infection exacerbates but does not cause resistance.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Breakthrough *Pneumocystis jirovecii* pneumonia in an immunocompromised patient on trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis is most commonly associated with mutations in the *Pneumocystis* dihydropteroate synthase (DHPS) gene, which confer resistance to sulfa drugs. This is a well-documented mechanism, especially in patients on long-term prophylaxis.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-009", "question": "A 50-year-old woman with rheumatoid arthritis on tofacitinib presents with symmetric polyarthritis flare, fever, and macular rash. Labs show pancytopenia, ferritin 10,000 ng/mL, triglycerides 400 mg/dL, and fibrinogen 100 mg/dL. Bone marrow biopsy reveals hemophagocytosis. What is the most appropriate initial treatment?", "options": ["High-dose glucocorticoids", "Cyclosporine A", "Anakinra", "Etoposide-based chemotherapy", "Intravenous immunoglobulin"], "answer": "C", "answer_index": 2, "explanation": "Anakinra, an IL-1 inhibitor, is effective for macrophage activation syndrome in rheumatoid arthritis, targeting cytokine storm and improving survival without broad immunosuppression. Glucocorticoids are adjunctive but insufficient alone in JAK inhibitor-associated cases. Etoposide is for refractory HLH but not first-line here.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has features of secondary hemophagocytic lymphohistiocytosis (HLH) in the setting of rheumatoid arthritis (likely macrophage activation syndrome, MAS) and tofacitinib use.  \nKey findings: fever, cytopenias, hyperferritinemia, hypertriglyceridemia, low fibrinogen, hemophagocytosis on bone marrow.  \n\nIn secondary HLH/MAS related to rheumatologic disease, first-line initial treatment is high-dose glucocorticoids (often intravenous methylprednisolone), sometimes with anakinra added, but glucocorticoids are the cornerstone initial therapy.  \nEtoposide-based regimens (like HLH-94) are typically reserved for primary HLH or severe/refractory secondary HLH, not the immediate first step in a rheumatology-associated MAS without failure of immunosuppression.  \n\nGiven the options, the most appropriate **initial** treatment here is high-dose glucocorticoids.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-010", "question": "A 65-year-old man with giant cell arteritis on prednisone taper develops jaw claudication and vision loss. ESR is 80 mm/hr, and temporal artery biopsy is negative. CTA shows aortic arch involvement. What is the most appropriate escalation in therapy?", "options": ["Increase prednisone to 60 mg daily", "Add methotrexate", "Initiate tocilizumab", "Start cyclophosphamide", "Perform temporal artery ultrasound"], "answer": "C", "answer_index": 2, "explanation": "Tocilizumab, an IL-6 inhibitor, is indicated for refractory giant cell arteritis with large vessel involvement, reducing relapse and steroid requirements. High-dose prednisone is initial but inadequate for escalation in biopsy-negative cases. Methotrexate is steroid-sparing but less effective for vision-threatening disease.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has giant cell arteritis with symptoms (jaw claudication and vision loss) and elevated ESR despite prednisone taper, plus evidence of large-vessel involvement (aortic arch on CTA).  \nA negative temporal artery biopsy does not rule out GCA, especially with large-vessel involvement.  \n\nGiven active disease on current steroid taper and risk of further vision loss or vascular complications, steroid-sparing immunosuppressive therapy is indicated.  \nTocilizumab (an IL-6 receptor inhibitor) is FDA-approved for GCA and shown to maintain remission and reduce steroid use.  \n\nIncreasing prednisone alone (A) would increase side effects without addressing need for steroid-sparing agent.  \nMethotrexate (B) is an option but less effective than tocilizumab for refractory GCA.  \nCyclophosphamide (D) is reserved for severe, refractory cases, usually after other agents fail.  \nTemporal artery ultrasound (E) is diagnostic, not therapeutic, and not needed here since CTA already shows large-vessel disease.  \n\n**The answer is C**"}]